Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.6100
+0.0252 (4.31%)
At close: May 22, 2026, 4:00 PM EDT
0.6338
+0.0238 (3.90%)
After-hours: May 22, 2026, 7:07 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $8.37 million as of May 22, 2026. Its market cap has decreased by -49.98% in one year.
Market Cap
8.37M
Enterprise Value
18.52M
1-Year Change
-49.98%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $8.37M, a decrease of -91.92%. That is a compound annual growth rate of -36.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 8.37M | -54.15% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Picard Medical | 13.94M |
| Trinity Biotech | 12.19M |
| Sintx Technologies | 10.32M |
| Tenon Medical | 8.11M |
| Nexalin Technology | 7.77M |
| Biomerica | 7.69M |
| enVVeno Medical | 7.32M |
| HeartSciences | 6.31M |